Glutamine Synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma

L-Glutamine (Gln) functions physiologically to balance the carbon and nitrogen requirements of tissues. It has been proposed that in cancer cells undergoing aerobic glycolysis, accelerated anabolism is sustained by Gln-derived carbons, which replenish the tricarboxylic acid (TCA) cycle (anaplerosis). However, it is shown here that in glioblastoma (GBM) cells, almost half of the Gln-derived glutamate (Glu) is secreted and does not enter the TCA cycle, and that inhibiting glutaminolysis does not affect cell proliferation. Moreover, Gln-starved cells are not rescued by TCA cycle replenishment. Instead, the conversion of Glu to Gln by glutamine synthetase (GS; cataplerosis) confers Gln prototrophy, and fuels de novo purine biosynthesis. In both orthotopic GBM models and in patients, 13C–glucose tracing showed that GS produces Gln from TCA-cycle-derived carbons. Finally, the Gln required for the growth of GBM tumours is contributed only marginally by the circulation, and is mainly either autonomously synthesized by GS-positive glioma cells, or supplied by astrocytes.

[1]  P. Xie,et al.  Glutamine synthetase functions as a negative growth regulator in glioma , 2013, Journal of Neuro-Oncology.

[2]  S. Sugano,et al.  Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species , 2010, Proceedings of the National Academy of Sciences.

[3]  C. Walsh,et al.  Mutations in QARS, encoding glutaminyl-tRNA synthetase, cause progressive microcephaly, cerebral-cerebellar atrophy, and intractable seizures. , 2014, American journal of human genetics.

[4]  T. Ishii,et al.  A novel function of glutamine in cell culture: Utilization of glutamine for the uptake of cystine in human fibroblasts , 1988, Journal of cellular physiology.

[5]  C. Watts,et al.  Abrogation of radioresistance in glioblastoma stem‐like cells by inhibition of ATM kinase , 2015, Molecular oncology.

[6]  Takahiro Takano,et al.  Glutamate release promotes growth of malignant gliomas , 2001, Nature Medicine.

[7]  W. Marston Linehan,et al.  Reductive carboxylation supports growth in tumor cells with defective mitochondria , 2011, Nature.

[8]  R. Deberardinis,et al.  Metabolism of [U‐13C]glucose in human brain tumors in vivo , 2012, NMR in biomedicine.

[9]  Paul Workman,et al.  Molecular and Phenotypic Characterisation of Paediatric Glioma Cell Lines as Models for Preclinical Drug Development , 2009, PloS one.

[10]  M. Cenzato,et al.  Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme. , 2013, Neuro-oncology.

[11]  Gabriela Kalna,et al.  Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase , 2011, Nature.

[12]  Andrei L Osterman,et al.  Comparative Metabolic Flux Profiling of Melanoma Cell Lines , 2011, The Journal of Biological Chemistry.

[13]  T. Shlomi,et al.  Fatty Acid Labeling from Glutamine in Hypoxia Can Be Explained by Isotope Exchange without Net Reductive Isocitrate Dehydrogenase (IDH) Flux , 2013, The Journal of Biological Chemistry.

[14]  D. Garfinkel,et al.  A simulation study of brain compartments. Metabolism of glutamate and related substances in mouse brain. , 1971, The Biochemical journal.

[15]  K. Vousden,et al.  iRFP is a sensitive marker for cell number and tumor growth in high-throughput systems , 2014, Cell cycle.

[16]  T. Fan,et al.  The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type. , 2012, Cell metabolism.

[17]  R. Deberardinis,et al.  Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo. , 2012, Cell metabolism.

[18]  Nicola Zamboni,et al.  Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells , 2007, The Journal of cell biology.

[19]  K. Behar,et al.  Characterization of Cerebral Glutamine Uptake from Blood in the Mouse Brain: Implications for Metabolic Modeling of 13C NMR Data , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[20]  G. Stephanopoulos,et al.  In vivo HIF-mediated reductive carboxylation is regulated by citrate levels and sensitizes VHL-deficient cells to glutamine deprivation. , 2013, Cell metabolism.

[21]  John M. Asara,et al.  Glutamine supports pancreatic cancer growth through a Kras-regulated metabolic pathway , 2013, Nature.

[22]  J. Tamburini,et al.  Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia. , 2013, Blood.

[23]  B O Palsson,et al.  Predictions for oxygen supply control to enhance population stability of engineered production strains , 1994, Biotechnology and bioengineering.

[24]  Christian M. Metallo,et al.  Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia , 2011, Nature.

[25]  M. Noble,et al.  Purified astrocytes promote the in vitro division of a bipotential glial progenitor cell. , 1984, The EMBO journal.

[26]  T. Taxt,et al.  Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma , 2011, Proceedings of the National Academy of Sciences.

[27]  A. Arcangeli,et al.  Glutamine depletion by crisantaspase hinders the growth of human hepatocellular carcinoma xenografts , 2014, British Journal of Cancer.

[28]  M E Meyerand,et al.  Classification of biopsy-confirmed brain tumors using single-voxel MR spectroscopy. , 1999, AJNR. American journal of neuroradiology.

[29]  B. Pollo,et al.  Epilepsy in glioblastoma multiforme: correlation with glutamine synthetase levels , 2009, Journal of Neuro-Oncology.

[30]  S. Niclou,et al.  Comprehensive Analysis of Glycolytic Enzymes as Therapeutic Targets in the Treatment of Glioblastoma , 2015, PloS one.

[31]  C. Dang,et al.  Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. , 2010, Cancer cell.

[32]  Ed Reznik,et al.  Flux Imbalance Analysis and the Sensitivity of Cellular Growth to Changes in Metabolite Pools , 2013, PLoS Comput. Biol..

[33]  H. Krebs.  Metabolism of amino-acids: The synthesis of glutamine from glutamic acid and ammonia, and the enzymic hydrolysis of glutamine in animal tissues. , 1935, The Biochemical journal.

[34]  E. White,et al.  Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids , 2013, Proceedings of the National Academy of Sciences.

[35]  Tsung-Cheng Chang,et al.  c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism , 2009, Nature.

[36]  Kami Kim,et al.  Bright and stable near infra-red fluorescent protein for in vivo imaging , 2011, Nature Biotechnology.

[37]  C. Tinelli,et al.  Glutamine Synthetase Immunostaining Correlates with Pathologic Features of Hepatocellular Carcinoma and Better Survival after Radiofrequency Thermal Ablation , 2010, Clinical Cancer Research.

[38]  Monica L. Mo,et al.  Global reconstruction of the human metabolic network based on genomic and bibliomic data , 2007, Proceedings of the National Academy of Sciences.

[39]  S. Mittelman,et al.  Glutaminase activity determines cytotoxicity of L-asparaginases on most leukemia cell lines. , 2015, Leukemia research.

[40]  P. Kalivas,et al.  The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities. , 2013, Antioxidants & redox signaling.

[41]  A. Lehninger,et al.  The pathways of glutamate and glutamine oxidation by tumor cell mitochondria. Role of mitochondrial NAD(P)+-dependent malic enzyme. , 1984, The Journal of biological chemistry.

[42]  Anthony Mancuso,et al.  Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction , 2008, Proceedings of the National Academy of Sciences.

[43]  G. Missale,et al.  L-Asparaginase and inhibitors of glutamine synthetase disclose glutamine addiction of β-catenin-mutated human hepatocellular carcinoma cells. , 2011, Current cancer drug targets.

[44]  L. Had‐Aissouni.  Toward a new role for plasma membrane sodium-dependent glutamate transporters of astrocytes: maintenance of antioxidant defenses beyond extracellular glutamate clearance , 2011, Amino Acids.

[45]  R. Deberardinis,et al.  Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis , 2007, Proceedings of the National Academy of Sciences.

[46]  D. Purich,et al.  Glutamine deprivation initiates reversible assembly of mammalian rods and rings , 2014, Cellular and Molecular Life Sciences.